Metraipolis › archive › dc_096de45afce7

GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research — Europe PMC PMID:41178720

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41178720
DOI
10.1172/jci194743
License (as archived)
solo-consultazione
Archived
2026-11-08T19:56:21.673Z
SHA-256 of the archived text
fd99259f5d468737daace19a314a70d42cef87e1a0519cef5a766b83f67423f6
Stable URL of this page
https://metraipolis.com/documento/dc_096de45afce7

How to cite

GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research — Europe PMC PMID:41178720 — Europe PMC (en), https://europepmc.org/article/MED/41178720 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_096de45afce7 (Metraipolis archive dc_096de45afce7, sha256 fd99259f5d468737daace19a314a70d42cef87e1a0519cef5a766b83f67423f6)
BibTeX
@misc{dc096de45afce7,
  title = {GLP-1 receptor agonists and cancer: current clinical evidence and translational opportunities for preclinical research — Europe PMC PMID:41178720},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41178720},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_096de45afce7; sha256 fd99259f5d468737daace19a314a70d42cef87e1a0519cef5a766b83f67423f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41178720. Agents can read the archived copy with the MCP tool read_document.